CVR 43610880Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)København NFounded 17 Oct 2022
Dandex has recorded no changes to this company since it began following the register.
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Fuse Vectors ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexEmployees
4
CVR registry, Aug 2026
-3 (-42.9%) over 12 months
Gross profit
-8.9M
DKK, annual report 2025
Result
-16.2M
DKK, annual report 2025
Equity
-23.7M
DKK, annual report 2025
Next Stage Ventures ApSCVR 37519111, 25% to under 33.3% of capital and votes, since 17 Oct 2022
Turnbull Biotech ApSCVR 43491938, 25% to under 33.3% of capital and votes, since 17 Oct 2022
and 2 moreJordan Philip Turnbullsince 17 Oct 2022
Benjamin Andre Frantisek Blahasince 17 Oct 2022
Equity was negative at 31 Dec 2025: -23.7M DKK. Dandex estimate, computed 6 Nov 2026.
CVR 3751911125% to under 33.3% of capital and votesnotified 30 Dec 2024since 17 Oct 2022
CVR 4349193825% to under 33.3% of capital and votesnotified 30 Dec 2024since 17 Oct 2022
25% to under 33.3% of capital and votesnotified 30 Dec 2024since 17 Oct 2022
10% to under 15% of capital and votessince 30 Dec 2024
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
17 Oct 2022 to 6 Nov 2026.
Aug 2026, monthly: 4 employees, 4 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | May 2023 | Jun 2023 | Jul 2023 | Aug 2023 | Sep 2023 | Oct 2023 | Nov 2023 | Dec 2023 | Jan 2024 | Feb 2024 | Mar 2024 | Apr 2024 | May 2024 | Jun 2024 | Jul 2024 | Aug 2024 | Sep 2024 | Oct 2024 | Nov 2024 | Dec 2024 | Jan 2025 | Feb 2025 | Mar 2025 | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 3 | 4 | 6 | 6 | 6 | 5 | 5 | 5 | 4 | 5 | 6 | 5 | 7 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 7 | 8 | 8 | 7 | 7 | 5 | 5 | 5 | 6 | 5 | 4 |
| FTE | 3 | 4 | 6 | 5 | 6 | 5 | 5 | 5 | 4 | 5 | 4 | 5 | 7 | 7 | 8 | 8 | 8 | 7 | 7 | 7 | 6 | 6 | 7 | 7 | 7 | 7 | 6 | 6 | 6 | 6 | 7 | 7 | 6 | 5 | 5 | 4 | 4 | 6 | 4 | 4 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's own headcount as CVR records it, not the annual report's average, which may cover a group. Monthly May 2023 to Aug 2026.
Latest Aug 2026, published 21 Oct 2026. Source: CVR employment series (Årsbeskæftigelse, Kvartalsbeskæftigelse, Månedsbeskæftigelse).
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Gross profit | -4,390 | -2,545 | -8,944 |
| Operating profit | -6,704 | -9,867 | -14,387 |
| Result for the year | -5,759 | -8,987 | -16,200 |
| Equity | -5,159 | 775 | -23,700 |
| Total assets | 4,575 | 20,728 | 9,032 |
| Employees (average) | 5 | 8 | 6 |
| Credit metrics (Dandex calculations) | |||
| EBITDA | -6,692 | -9,854 | -14,106 |
| Employee growth (vækst i antal ansatte) | Not reportednote 1 | 60% | -14.3% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | 6,073 | 14,291 | 26,867 |
| ROIC (afkast af investeret kapital) | Not reportednote 2 | -96.3%note 3 | -127.1%note 3 |
| Capex (investeringer i anlægsaktiver) | 63note 4 | 0note 5 | 1,546note 4 |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | 6,728 | 14,980 | 27,790 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group. Not every period is a full year: 2023 covers 14 months (17 Oct 2022 to 31 Dec 2023). Changes against it compare periods of different length.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. No cash flow statement filed (class A and B are exempt).
Each registered value from the day it took effect, newest first.
From CVR, read 6 Nov 2026. Text such as the signing rule and purpose is shown as registered.
7 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Revision:
Tiltrådte:
CVR-NR. 33771231 PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB, Strandvejen 44, 2900 Hellerup, den 26.06.2025.
Vedtægterne er yderligere ændret
Vedtægter ændret: 30.12.2024
Selskabet tegnes af 2 medlemmer af bestyrelsen i forening, af 1 direktør i forening med bestyrelsesformanden, eller af den samlede bestyrelse.
Direktion:
Fratrådte:
Henrik Stage, (adm. dir), den 01.04.2025, Jordan Philip Turnbull, den 01.04.2025.
Tiltrådte:
Jordan Philip Turnbull, (adm. dir), den 01.04.2025.
Vedtægter ændret: 30.12.2024
Kapitalforhøjelsen er besluttet den 30.12.2024.
kr. 6.222,00, indbetalt kontant, kurs 239.825,35.
Kapitalen udgør herefter kr. 48.222,00.
Bestyrelse:
Tiltrådte:
Henrik Stage, (formand), den 30.12.2024, Jordan Philip Turnbull, den 30.12.2024, Alexis Alihonou Houssou, den 30.12.2024, Benjamin Andre Frantisek Blaha, den 30.12.2024.
Vedtægter ændret: 29.02.2024
Selskabet tegnes af to medlemmer af direktionen i forening eller af den samlede direktion.
Ny adresse: c/o Bio Innovation Institute, Ole Maaløes Vej 3, 2200 København N
Ny kommune: København
Stiftelsesdato: 17.10.2022.
Virkningsdato: 17.10.2022.
Seneste vedtægtsdato: 17.10.2022.
Kapital:
kr. 42.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 42.000,00 til kurs 1.428,57, fuldt indbetalt.
Stiftere:
Blaha Bioscience BV, Cornelis Anthoniszstraat 7H , 1071VS Amsterdam, Holland, den 17.10.2022, CVR-NR. 37519111 Next Stage Ventures ApS, c/o Henrik Stage, Gl Strandvej 250, 3050 Humlebæk, den 17.10.2022, CVR-NR. 43491938 Turnbull Biotech ApS, Bodenhoffs Plads 12, 2. tv, 1430 København K, den 17.10.2022.
Direktion:
Henrik Stage, (adm. dir), den 17.10.2022, Jordan Philip Turnbull, den 17.10.2022, Benjamin Andre Frantisek Blaha, den 17.10.2022.
Selskabet tegnes af en direktør.
Første regnskabsår:
17.10.2022 - 31.12.2023.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er at udføre forskning og udvikling indenfor bioteknologi.
1 registered in CVR.
P-number 1028704654Ole Maaløes Vej 3, 2200 København N
No other current company drawn.
No other current company drawn.
